Joe Tippens’ story is often cited in discussions about unconventional cancer treatments. Diagnosed with advanced lung cancer, he later reported remission after using an off-label medication originally intended for animals, alongside standard care. His case has fueled debate about drug repurposing, anecdotal outcomes, and the limits of current cancer research—while doctors stress that such claims don’t replace clinical evidence or medical guidance.